Inari Medical Inc. (NARI)
NASDAQ: NARI
· Real-Time Price · USD
79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| Non-Us Revenue | 23.77M | 9.43M |
| Non-Us Revenue Growth | +152.02% | n/a |
| United States Revenue | 469.86M | 374.04M |
| United States Revenue Growth | +25.62% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 108.27M | 113.05M | 103.06M | 92.66M | 88.28M | 85.59M | 85.7M | 80.12M | 75.83M | 73.16M | 63.73M | 54.47M | 56.1M | 42.9M | 36.9M | 31.39M | 23.08M | 18.88M | 16.39M | 13.87M | 10.1M | 7.8M | 5.43M |
| Selling, General, and Administrative Revenue Growth | -4.23% | +9.70% | +11.22% | +4.96% | +3.15% | -0.13% | +6.96% | +5.66% | +3.66% | +14.79% | +17.01% | -2.92% | +30.79% | +16.26% | +17.54% | +36.02% | +22.25% | +15.17% | +18.20% | +37.32% | +29.44% | +43.81% | n/a |
| Research and Development Revenue | 29.43M | 24.91M | 26.88M | 22.89M | 21.49M | 21.09M | 22.06M | 20.41M | 19.11M | 18.57M | 16.14M | 18.73M | 12.5M | 11.63M | 8.16M | 6.54M | 5.22M | 3.63M | 3.02M | 2.71M | 1.72M | 1.58M | 1.21M |
| Research and Development Revenue Growth | +18.17% | -7.35% | +17.42% | +6.51% | +1.93% | -4.44% | +8.09% | +6.84% | +2.89% | +15.09% | -13.84% | +49.82% | +7.47% | +42.47% | +24.91% | +25.26% | +43.80% | +20.21% | +11.41% | +57.31% | +8.99% | +30.68% | n/a |